Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I/II Randomized, Double Blinded, Placebo Controlled Trial to Evaluate the Safety and Potential Efficacy of NANOVAE Injected Intra-Articular in Patients Suffering With Knee Osteoarthritis

NCT06606561 is registered in ClinicalTrials.gov with Nova Vita Laboratory as lead sponsor.

NCT NCT06606561
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06606561 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I/II Randomized, Double Blinded, Placebo Controlled Trial to Evaluate the Safety and Potential Efficacy of NANOVAE Injected Intra-Articular in Patients Suffering With Knee Osteoarthritis
Lead sponsor
Nova Vita Laboratory
Phase
Phase 1/2
Overall status
Not yet recruiting
Start date
October 1, 2026
Completion date
October 1, 2027
Enrollment
24 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

knee osteoarthritis